Cellbion Co., Ltd. engages in the research and development of imaging agents for diagnosis, cosmetics for hospitals, and functional health foods. It focus on the research and development of prostate cancer treatments. The company was founded by Kwon Kim on July 21, 2010 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company